Multiple Sclerosis (MS) is an autoimmune inflammatory disease that affects the Central Nervous System (CNS) by interfering with nerve signal transmission. Most individuals diagnosed with Secondary Progressive Multiple Sclerosis (SPMS) are initially diagnosed with Relapse Remitting Multiple Sclerosis. SPMS is characterized by a steady progression of symptoms overtime with a decrease in relapses. Relapses in SPMS are less frequent or nonexistent and recovery to original functioning is less common. The cause of the transition from Relapse Remitting Multiple Sclerosis to Secondary Progressive Multiple Sclerosis is unclear. This transition typically occurs 10-20 years after primary diagnosis.
Laverne is a handy bioinformatics tool to help facilitate scientific exploration of related genes, diseases and pathways based on co-citations. Explore more on Secondary Progressive Multiple Sclerosis below!
For more information on how to use Laverne, please read the How to Guide.
We have 2684 products for the study of Secondary Progressive Multiple Sclerosis that can be applied to Chromatin Immunoprecipitation, Western Blot, Flow Cytometry, Immunocytochemistry/Immunofluorescence, Immunohistochemistry from our catalog of antibodies and ELISA kits.